“Exosome-Inspired Liposomal Nanocarriers for Precision Methotrexate Delivery in Rheumatoid Arthritis”
-∞ of 54.3 ± 2.8 µg h/mL and showed 76.8% reduce in paw edema in collagen-induced arthritis animals. Histopathology analysis found that joints were better protected and there was decreased inflammation and cartilage damage. The results show that EMLs are a reliable and biocompatible way to carry out safe, effective and targeted treatment of rheumatoid arthritis.
Authors
- Tora Shah
- Gaurav Tiwari (ORCID: https://orcid.org/0000-0003-2200-737X)
- Praveen Katiyar (ORCID: https://orcid.org/0000-0001-5902-8073)
- Manish R. Bhise (ORCID: https://orcid.org/0000-0002-3848-2549)
- Sekar Variavel (ORCID: https://orcid.org/0009-0008-0538-0280)
- Rao V (ORCID: https://orcid.org/0009-0002-1058-863X)
- Pankaj Kumar Sharma (ORCID: https://orcid.org/0000-0003-0211-9606)
Institutions
- Sant Gadge Baba Amravati University (IN)
- American Association of Colleges of Pharmacy (US)
- Chhatrapati Shahu Ji Maharaj University (IN)
- Knoxville College (US)
- Parul University (IN)
Publication Details
- Journal
- Journal of drug targeting
- Published
- 2026-05-12
- DOI
- https://doi.org/10.1080/1061186x.2026.2669792
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00